These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 21371541)

  • 21. Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.
    Koester LS; Mayorga P; Pereira VP; Petzhold CL; Bassani VL
    Drug Dev Ind Pharm; 2003 Feb; 29(2):145-54. PubMed ID: 12648011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
    Ribeiro L; Ferreira DC; Veiga FJ
    J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mathematical evaluation of in vitro release profiles of hydroxypropylmethylcellulose matrix tablets containing carbamazepine associated to beta-cyclodextrin.
    Koester LS; Ortega GG; Mayorga P; Bassani VL
    Eur J Pharm Biopharm; 2004 Jul; 58(1):177-9. PubMed ID: 15207552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physicochemical characteristics and oral bioavailability of andrographolide complexed with hydroxypropyl-beta-cyclodextrin.
    Ren K; Zhang Z; Li Y; Liu J; Zhao D; Zhao Y; Gong T
    Pharmazie; 2009 Aug; 64(8):515-20. PubMed ID: 19746840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of HPMC concentration on β-cyclodextrin solubilization of norfloxacin.
    Loh GO; Tan YT; Peh KK
    Carbohydr Polym; 2014 Jan; 101():505-10. PubMed ID: 24299805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and in vitro/in vivo investigation of carbamazepine controlled-release matrix tablets.
    Ikinci G; Capan Y; Senel S; Dalkara T; Hincal AA
    Pharmazie; 1999 Feb; 54(2):139-41. PubMed ID: 10084159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
    Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
    Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orodispersible Carbamazepine/Hydroxypropyl-β-Cyclodextrin Tablets Obtained by Direct Compression with Five-in-One Co-processed Excipients.
    Conceição J; Adeoye O; Cabral-Marques H; Concheiro A; Alvarez-Lorenzo C; Sousa Lobo JM
    AAPS PharmSciTech; 2020 Jan; 21(2):39. PubMed ID: 31897724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
    Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
    Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability in commercial carbamazepine samples--impact on drug release.
    Flicker F; Eberle VA; Betz G
    Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs.
    Zhang N; Zhang W; Jin Y; Quan DQ
    Pharm Dev Technol; 2011 Aug; 16(4):415-21. PubMed ID: 20433250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
    Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
    Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.